ODE Cardiovascular Division Plans Reorganization, Review Enhancements

A proposal to increase the number of review branches within the Center for Devices and Radiological Health's Division for Cardiovascular and Respiratory Devices from four to six could be finalized in the next several weeks, according to FDA staffers.